Garmin International, Inc. recently announced a collaboration with ActiGraph to create health and activity monitoring solutions for academic research, clinical trials, and remote patient monitoring.
PENSACOLA, Fla. and NASHVILLE, Tenn., Jan. 7, 2025 /PRNewswire/ -- ActiGraph, the global leader in wearable digital health technology for clinical research and development, has announced the ...
ArchiMed acquired ActiGraph, which provides wearable, remote monitoring of mobility and sleep for drug trials. ArchiMed is buying 75 percent of ActiGraph in an all-equity deal, with company management ...
This morning, Garmin and medical-grade monitor maker ActiGraph announced a new partnership that will focus on wearables for medical research and patient care. Specifically, the pair will be applying ...
ActiGraph, a maker of wearables and software used by drug companies in clinical trials, on Tuesday announced it acquired the life sciences business of Biofourmis, a digital health startup once ...
Tech-giant Garmin is stepping into the medical wearables space through a new collaboration with ActiGraph. The partnership will explore health and activity monitoring innovations combining Garmin ...
Background/aim Consumer-based physical activity (PA) monitors have become popular tools to track PA behaviours. Currently, little is known about the validity of the measurements provided by consumer ...
As drugmakers wade into using digital health technologies, ActiGraph has made its mission to become the wearable of choice for the industry. The Pensacola, Fla.-based company creates devices and ...
NEW YORK--(BUSINESS WIRE)--Edgemont Partners (“Edgemont”), a prominent middle-market healthcare investment bank and a leading M&A advisor to pharmaceutical services and eClinical technology companies, ...
PROVIDENCE, RI--(Marketwired - May 9, 2016) - Vector Software, the world's leading provider of innovative software solutions for embedded software quality, announced today that ActiGraph, a global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results